Shan-Shan Guo

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Yuan Li, Guo-Dong Jia, Xiaofei Lv et al. · Nature Communications · 2023 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13

Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

Ting Liu, Di Dong, Xun Zhao et al. · BMC Medicine · 2023 · 25 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial

Xun Cao, Hao‐Yang Huang, Chixiong Liang et al. · Nature Communications · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17